| Autor: |
Jin-Ju Jeong, Hee Jin Park, Min Gi Cha, Eunju Park, Sung-Min Won, Raja Ganesan, Haripriya Gupta, Yoseph Asmelash Gebru, Satya Priya Sharma, Su Been Lee, Goo Hyun Kwon, Min Kyo Jeong, Byeong Hyun Min, Ji Ye Hyun, Jung A Eom, Sang Jun Yoon, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Microorganisms, Vol 10, Iss 2, p 288 (2022) |
| Druh dokumentu: |
article |
| ISSN: |
2076-2607 |
| DOI: |
10.3390/microorganisms10020288 |
| Popis: |
Over the past decade, scientific evidence for the properties, functions, and beneficial effects of probiotics for humans has continued to accumulate. Interest in the use of probiotics for humans has increased tremendously. Among various microorganisms, probiotics using bacteria have been widely studied and commercialized, and, among them, Lactobacillus is representative. This genus contains about 300 species of bacteria (recently differentiated into 23 genera) and countless strains have been reported. They improved a wide range of diseases including liver disease, gastrointestinal diseases, respiratory diseases, and autoimmune diseases. Here, we intend to discuss in depth the genus Lactobacillus as a representative probiotic for chronic liver diseases. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
